Nucleus Biologics launched the Krakatoa® K500, a pod-based, on-demand manufacturing system that produces 35–500L of media and ...

SAN FRANCISCO--(BUSINESS WIRE)--Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application ...

Bioreactor makers should consider using additive manufacturing, also known as 3D printing, according to a study, which suggests the potential benefits of the approach would be worth the investment.

Bioreactors have become irreplaceable tools in bioprocessing, revolutionizing the production of many biotechnological products. 1,2 They offer optimized and controlled environments to enhance cell ...

FREDERICK, Md. and PLANO, Texas, Oct. 6, 2025 /PRNewswire/ -- RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development ...

Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, ...

SOURCE WuXi PharmaTech (Cayman) Inc. SHANGHAI and TAIPEI, Oct. 30, 2013 - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing ...

The first commercial monoclonal antibody (mAb) was approved in 1986 and today, the global market is large and growing. Reports estimate the size of the market to be approximately $100 billion with ...

Designed specifically for bioreactor-scale workflows, the Krakatoa (R) K500 requires less than 15 minutes of hands-on time and produces up to 500 liters in less than three hours. Two standard pod ...